Literature DB >> 9315909

CREB (cAMP response element-binding protein) in the locus coeruleus: biochemical, physiological, and behavioral evidence for a role in opiate dependence.

S B Lane-Ladd1, J Pineda, V A Boundy, T Pfeuffer, J Krupinski, G K Aghajanian, E J Nestler.   

Abstract

Chronic morphine administration increases levels of adenylyl cyclase and cAMP-dependent protein kinase (PKA) activity in the locus coeruleus (LC), which contributes to the severalfold activation of LC neurons that occurs during opiate withdrawal. A role for the transcription factor cAMP response element-binding protein (CREB) in mediating the opiate-induced upregulation of the cAMP pathway has been suggested, but direct evidence is lacking. In the present study, we first demonstrated that the morphine-induced increases in adenylyl cyclase and PKA activity in the LC are associated with selective increases in levels of immunoreactivity of types I and VIII adenylyl cyclase and of the catalytic and type II regulatory subunits of PKA. We next used antisense oligonucleotides directed against CREB to study the role of this transcription factor in mediating these effects. Infusion (5 d) of CREB antisense oligonucleotide directly into the LC significantly reduced levels of CREB immunoreactivity. This effect was sequence-specific and not associated with detectable toxicity. CREB antisense oligonucleotide infusions completely blocked the morphine-induced upregulation of type VIII adenylyl cyclase but not of PKA. The infusions also blocked the morphine-induced upregulation of tyrosine hydroxylase but not of Gialpha, two other proteins induced in the LC by chronic morphine treatment. Electrophysiological studies revealed that intra-LC antisense oligonucleotide infusions completely prevented the morphine-induced increase in spontaneous firing rates of LC neurons in brain slices. This blockade was completely reversed by addition of 8-bromo-cAMP (which activates PKA) but not by addition of forskolin (which activates adenylyl cyclase). Intra-LC infusions of CREB antisense oligonucleotide also reduced the development of physical dependence to opiates, based on attenuation of opiate withdrawal. Together, these findings provide the first direct evidence that CREB mediates the morphine-induced upregulation of specific components of the cAMP pathway in the LC that contribute to physical opiate dependence.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9315909      PMCID: PMC6793917     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  47 in total

1.  Distinct patterns of cAMP-dependent protein kinase gene expression in mouse brain.

Authors:  G Cadd; G S McKnight
Journal:  Neuron       Date:  1989-07       Impact factor: 17.173

2.  Type I calmodulin-sensitive adenylyl cyclase is neural specific.

Authors:  Z Xia; E J Choi; F Wang; C Blazynski; D R Storm
Journal:  J Neurochem       Date:  1993-01       Impact factor: 5.372

3.  Distribution of type II adenylyl cyclase mRNA in the rat brain.

Authors:  T Furuyama; S Inagaki; H Takagi
Journal:  Brain Res Mol Brain Res       Date:  1993-07

4.  Protein kinases in the locus coeruleus and periaqueductal gray matter are involved in the expression of opiate withdrawal.

Authors:  R Maldonado; O Valverde; C Garbay; B P Roques
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-11       Impact factor: 3.000

5.  Reduction of morphine abstinence in mice with a mutation in the gene encoding CREB.

Authors:  R Maldonado; J A Blendy; E Tzavara; P Gass; B P Roques; J Hanoune; G Schütz
Journal:  Science       Date:  1996-08-02       Impact factor: 47.728

Review 6.  Adenylyl cyclases and the interaction between calcium and cAMP signalling.

Authors:  D M Cooper; N Mons; J W Karpen
Journal:  Nature       Date:  1995-03-30       Impact factor: 49.962

7.  Amphetamine regulates gene expression in rat striatum via transcription factor CREB.

Authors:  C Konradi; R L Cole; S Heckers; S E Hyman
Journal:  J Neurosci       Date:  1994-09       Impact factor: 6.167

8.  Opiates suppress a resting sodium-dependent inward current and activate an outward potassium current in locus coeruleus neurons.

Authors:  M Alreja; G K Aghajanian
Journal:  J Neurosci       Date:  1993-08       Impact factor: 6.167

9.  Evidence for G protein mediation of serotonin- and GABAB-induced hyperpolarization of rat dorsal raphe neurons.

Authors:  R B Innis; E J Nestler; G K Aghajanian
Journal:  Brain Res       Date:  1988-08-30       Impact factor: 3.252

10.  Lewis and Fischer rat strains display differences in biochemical, electrophysiological and behavioral parameters: studies in the nucleus accumbens and locus coeruleus of drug naive and morphine-treated animals.

Authors:  X Guitart; J H Kogan; M Berhow; R Z Terwilliger; G K Aghajanian; E J Nestler
Journal:  Brain Res       Date:  1993-05-14       Impact factor: 3.252

View more
  76 in total

1.  Role for GDNF in biochemical and behavioral adaptations to drugs of abuse.

Authors:  C J Messer; A J Eisch; W A Carlezon; K Whisler; L Shen; D H Wolf; H Westphal; F Collins; D S Russell; E J Nestler
Journal:  Neuron       Date:  2000-04       Impact factor: 17.173

2.  G-protein-gated potassium channels containing Kir3.2 and Kir3.3 subunits mediate the acute inhibitory effects of opioids on locus ceruleus neurons.

Authors:  Maria Torrecilla; Cheryl L Marker; Stephanie C Cintora; Markus Stoffel; John T Williams; Kevin Wickman
Journal:  J Neurosci       Date:  2002-06-01       Impact factor: 6.167

Review 3.  Ubiquitin-mediated proteolysis in learning and memory.

Authors:  D G Chain; J H Schwartz; A N Hegde
Journal:  Mol Neurobiol       Date:  1999 Oct-Dec       Impact factor: 5.590

4.  Repeated cocaine self-administration causes multiple changes in rat frontal cortex gene expression.

Authors:  Willard M Freeman; Karen Brebner; Kruti M Patel; Wendy J Lynch; David C S Roberts; Kent E Vrana
Journal:  Neurochem Res       Date:  2002-10       Impact factor: 3.996

5.  Impaired D2 dopamine receptor function in mice lacking type 5 adenylyl cyclase.

Authors:  Ko-Woon Lee; Jang-Hee Hong; In Young Choi; Yongzhe Che; Ja-Kyeong Lee; Sung-Don Yang; Chang-Woo Song; Ho Sung Kang; Jae-Heun Lee; Jai Sung Noh; Hee-Sup Shin; Pyung-Lim Han
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

6.  Reciprocal modulation of phospholipase Cbeta isoforms: adaptation to chronic morphine.

Authors:  Sumita Chakrabarti; Nai-Jiang Liu; Alan R Gintzler
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-03       Impact factor: 11.205

Review 7.  Virogenetic and optogenetic mechanisms to define potential therapeutic targets in psychiatric disorders.

Authors:  Ming-Hu Han; Allyson K Friedman
Journal:  Neuropharmacology       Date:  2011-09-17       Impact factor: 5.250

Review 8.  Opioid receptor trafficking and signaling: what happens after opioid receptor activation?

Authors:  Jia-Ming Bian; Ning Wu; Rui-Bin Su; Jin Li
Journal:  Cell Mol Neurobiol       Date:  2011-09-25       Impact factor: 5.046

9.  How to design an opioid drug that causes reduced tolerance and dependence.

Authors:  Amy Chang Berger; Jennifer L Whistler
Journal:  Ann Neurol       Date:  2010-05       Impact factor: 10.422

10.  Spinal administration of lipoxygenase inhibitors suppresses behavioural and neurochemical manifestations of naloxone-precipitated opioid withdrawal.

Authors:  Tuan Trang; Maaja Sutak; Remi Quirion; Khem Jhamandas
Journal:  Br J Pharmacol       Date:  2003-08-26       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.